These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7417030)

  • 1. The effects of homologous cross-circulation and in situ liver perfusion on fulminant hepatic failure rats.
    Mohsini K; Lister C; Chang TM
    Artif Organs; 1980 Aug; 4(3):171-5. PubMed ID: 7417030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in treating experimentally induced acute hepatic failure by hemoperfusion or cross circulation.
    Chamuleau RA; Popken RJ; Beyerbacht EC; De Koning HW
    Hepatology; 1983; 3(5):696-700. PubMed ID: 6688604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
    Chirito E; Reiter B; Lister C; Chang TM
    Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma.
    Ryan CJ; Anilkumar T; Ben-Hamida AJ; Khorsandi SE; Aslam M; Pusey CD; Gaylor JD; Courtney JM
    Artif Organs; 2001 Feb; 25(2):109-18. PubMed ID: 11251476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.
    Chirito E; Lister C; Chang TM
    Artif Organs; 1979 Feb; 3(1):42-6. PubMed ID: 435123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats.
    Tabata Y; Chang TM
    Trans Am Soc Artif Intern Organs; 1980; 26():394-9. PubMed ID: 7245521
    [No Abstract]   [Full Text] [Related]  

  • 7. The anti-proliferative effect of plasma from rats with acute fulminant hepatic failure.
    Anilkumar T; Ryan CJ; Aslam M; Poulsom R; Alison M
    Scand J Gastroenterol; 1997 Nov; 32(11):1152-61. PubMed ID: 9399398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternations of liver pathophysiology in experimental hepatic failure treated by two forms of plasma purification procedure.
    Ouchi K; Okabe K; Asanuma Y; Koyama K; Sato T
    Tohoku J Exp Med; 1985 Jun; 146(2):211-23. PubMed ID: 4024095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems.
    Dixit V; Chang TM
    ASAIO Trans; 1990; 36(1):21-7. PubMed ID: 2306387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-dialysis in the treatment of experimental fulminant hepatic coma.
    Santiago-Delpín EA; Callender C; Kjellstrand CM; Buselmeier TJ; Najarian JS
    J Surg Res; 1975 Sep; 19(3):175-82. PubMed ID: 1165632
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model.
    Dixit V; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):559-73. PubMed ID: 3481555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacies of whole blood and plasma cross circulation on galactosamine induced hepatic failure rats.
    Okabe K; Ouchi K; Koyama K; Sato T
    Trans Am Soc Artif Intern Organs; 1984; 30():395-8. PubMed ID: 6533913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of charcoal hemoperfusion on amino acid disturbance in experimental hepatic coma.
    Shi ZQ; Chang TM
    Int J Artif Organs; 1984 Jul; 7(4):203-8. PubMed ID: 6490192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homologous plasma cross-circulation on galactosamine induced hepatic failure rats].
    Ouchi K; Koyama K; Asanuma Y; Okabe K; Sato T
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):452-6. PubMed ID: 6749113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
    Dixit V; Chang TM
    Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats.
    Shu CD; Chang TM
    Int J Artif Organs; 1983 Sep; 6(5):273-7. PubMed ID: 6642726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review.
    Chang TM
    Semin Liver Dis; 1986 May; 6(2):148-58. PubMed ID: 3529408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term cross-circulation on galactosamine induced hepatic failure rats].
    Okabe K; Koyama K; Ouchi K; Asanuma Y; Sato T
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):445-51. PubMed ID: 6749112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of homologous plasma cross-circulation on liver function in galactosamine-induced hepatic necrosis in rats.
    Ouchi K; Okabe K; Asanuma Y; Koyama K; Sato T
    Artif Organs; 1984 May; 8(2):179-85. PubMed ID: 6732545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.